Litcius/Paper detail

Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532

Fumihito Ushiyama, Hajime Takashima, Yohei Matsuda, Yuya Ogata, Naoki Sasamoto, Risa Kurimoto-Tsuruta, Kaori Ueki, Nozomi Tanaka-Yamamoto, Mayumi Endo, Masashi Mima, Kiyoko Fujita, Iichiro Takata, Satoshi Tsuji, Haruhiro Yamashita, Hirotoshi Okumura, Katsumasa Otake, Hiroyuki Sugiyama

2020Bioorganic & Medicinal Chemistry25 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryKlebsiella pneumoniaeHydroxymethylPharmacologyDrugBacteriaMoietyEscherichia coliBiochemistryStereochemistryBiologyGeneticsGeneAntibiotic Resistance in BacteriaPneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory Infections
Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532 | Litcius